NCT04290494View on ClinicalTrials.gov

Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed;

CompletedOBSERVATIONAL
Enrollment

42,188

Participants

Timeline

Start Date

September 21, 2020

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Stroke
Interventions
DRUG

IV rtPA (intravenous recombinant plasminogen activator)

intravenous injection

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04290494 - Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed; | Biotech Hunter | Biotech Hunter